NHFG
SGMO

New Harbor Financial Group’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

New Harbor Financial Group’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,410
Closed -$9.02K – 81
2024
Q3 		$9.02K Hold
10,410
– – ﹤0.01% 69
2024
Q2 		$3.73K Hold
10,410
– – ﹤0.01% 64
2024
Q1 		$6.98K Hold
10,410
– – ﹤0.01% 51
2023
Q4 		$5.66K Hold
10,410
– – ﹤0.01% 46
2023
Q3 		$6.24K Hold
10,410
– – ﹤0.01% 46
2023
Q2 		$13.5K Hold
10,410
– – ﹤0.01% 47
2023
Q1 		$18.3K Hold
10,410
– – 0.01% 37
2022
Q4 		$32.7K Hold
10,410
– – 0.01% 38
2022
Q3 		$51K Buy
+10,410
New +$53.5K 0.03% 24

Other funds holding SGMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

New Harbor Financial Group's SGMO Position: Q4 2024 in Review

New Harbor Financial Group sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2024, closing a stake of 10,410 shares — an estimated $9.02K sold.

New Harbor Financial Group first reported a position in SGMO in Q3 2022 and held it in 9 quarters. The position peaked at $51K in Q3 2022. 128 funds tracked by Wall St. Rank hold SGMO as of Q4 2024.

  • New Harbor Financial Group reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2024 after selling out during the quarter.
  • New Harbor Financial Group sold 10,410 SANGAMO THERAPEUTICS INC shares in Q4 2024, an estimated $9.02K.
  • New Harbor Financial Group first reported a position in SANGAMO THERAPEUTICS INC in Q3 2022 and held it in 9 quarters.
  • New Harbor Financial Group's SANGAMO THERAPEUTICS INC position peaked at $51K in Q3 2022.
  • 128 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2024.

Based on New Harbor Financial Group's 13F filing for Q4 2024, filed 17 Jan 2025.